Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

In an internal memo, sent Dec. 17, 2024, CancerCare Manitoba recommended community cancer care program directors and managers ...

The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...